Prothena Corp. plc buy Citigroup Inc.
Start price
28.02.23
/
50%
€53.02
Target price
28.02.24
€67.71
Performance (%)
-49.45%
End price
29.02.24
€26.80
Summary
This prediction ended on 29.02.24 with a price of €26.80. Massive losses of -49.45% were the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Prothena Corp. plc | 12.162% | 12.162% | -31.405% | -81.390% |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% | 43.350% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% | 72.418% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% | 43.435% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% | 54.983% |
Comments by Citigroup_Inc_ for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Citigroup Inc. from $76.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
In the thread Trading Prothena Corp. plc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

